NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 29 of 29 results found.

Activity Company Description Location
Company APIE Therapeutics Inc. Activity: Research and Development Research and Development Company Description

APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies.

Location Cary
Company Aegis Surgical Ltd. Activity: Research and Development Research and Development Company Description AEGIS is developing a less invasive access system that facilitates percutaneous transaortic transcatheter aortic valve replacement (pTAo-TAVR). Location Durham
Company Affinergy LLC Activity: Research and Development Research and Development Company Description Affinergy develops peptide-based technologies, including diagnostic products, research tools and therapeutic drug monitoring products for use by clinicians and researchers. Location Morrisville
Company AskBio Activity: Research and Development Research and Development Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. Location Research Triangle Park
Company Basking Biosciences Inc. Activity: Research and Development Research and Development Company Description Basking Biosciences is developing a reversible anti-thrombotic therapeutic to treat ischemic stroke. Location Research Triangle Park
Company CardioPharma Inc. Activity: Research and Development Research and Development Company Description CardioPharma develops combinatorial products to treat cardiovascular disease. Location Wilmington
Company Catalyst Medicine LLC Activity: Research and Development Research and Development Company Description Catalyst Medicine designs, develops and commercializes Class 1 and Class 2 medical devices in the areas of neurology, orthopedics, cardiology and plastic surgery. Location Durham
Company Cathtek Inc. Activity: Research and Development Research and Development Company Description Cathtek develops and manufactures catheters and related accessories. Location Winston-Salem
Company Chiesi USA Inc. Activity: Research and Development Research and Development Company Description Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A, develops and commercializes products in the therapeutic areas of rare disease, respiratory, cardiovascular, neonatology and cystic fibrosis. Location Cary
Company Contego Medical LLC Activity: Research and Development Research and Development Company Description Contego Medical develops embolic protection devices for cardiovascular and peripheral vascular procedures, designed to simplify catheter-based procedures. Location Raleigh
Company Harmony Development Group Activity: Research and Development Research and Development Company Description Harmony Development Group is developing a passive intra-ventricular cardiac assist device that can slow down, stop and even reverse the cascade of heart failure dysfunction. Location Cornelius
Company Humacyte Inc. Activity: Research and Development Research and Development Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. Location Durham
Company InnAVasc Medical Inc. Activity: Research and Development Research and Development Company Description InnAVasc Medical designs and develops products for vascular access. The company's first technology is an arteriovenous graft (AVG) modification that facilitates graft access and safety in hemodialysis. Location Durham
Company Kowa Research Institute Inc. Activity: Research and Development Research and Development Company Description Kowa Research Institute, a division of Kowa Company Ltd., develops therapeutic drugs for the treatment of cardio-metabolic diseases such as diabetes and atherosclerosis, pain and sensory organ disorders. Location Morrisville
Company Liquidia Technologies Inc. Activity: Research and Development Research and Development Company Description Liquidia Technologies develops and commercializes human therapeutics for the treatment of pulmonary arterial hypertension and post-operative pain using its proprietary particle engineering technology. Location Morrisville
Company MD Scientific LLC Activity: Research and Development Research and Development Company Description MD Scientific developed the EndoTool Glucose Management System and is currently developing a drug to prevent kidney and heart injury from iodinated contrast agents. Location Charlotte
Company Micell Technologies Inc. Activity: Research and Development Research and Development Company Description Micell Technologies develops combination-product therapies for interventional cardiology. Micell markets MiStent, a drug-eluting stent, in Europe and certain other regions. Location Durham
Company Milestone Pharmaceuticals USA Inc. Activity: Research and Development Research and Development Company Description Milestone Pharmaceuticals is developing an investigational new drug intended to provide rapid-onset and short-acting treatment of paroxysmal supraventricular tachycardia (PSVT) episodes and other episodic conditions. Location Charlotte
Company NuPulseCV Activity: Research and Development Research and Development Company Description NuPulseCV is developing an implantable cardiovascular left ventricular assist device to treat people suffering from congestive heart failure. Location Raleigh
Company Phoenix Cardiac Devices Inc. Activity: Research and Development Research and Development Company Description Phoenix Cardiac Devices is designing and developing a cardiac device to treat functional mitral valve regurgitation. Location Cary
Company QuatroBio LLC Activity: Research and Development Research and Development Company Description QuatroBio provides oversight and strategic direction to several closely held drug development companies. Location Morrisville
Company Shear Induced Technologies Activity: Research and Development Research and Development Company Description ShearIT is developing and commercializing Lamiflo, a non-pharmacologic treatment for cerebrovascular disease. Location Lewisville
Company SonoVascular Inc. Activity: Research and Development Research and Development Company Description SonoVascular is developing a thrombolysis device for the treatment of blood clots related to deep vein thrombosis, pulmonary embolism and peripheral arterial occlusions. Location Chapel Hill
Company Tenax Therapeutics Inc. Activity: Research and Development Research and Development Company Description Tenax Therapeutics develops and commercializes pharmaceutical products for the critical care market. Location Morrisville
Company United Therapeutics Corp. Activity: Research and Development Research and Development Company Description United Therapeutics develops and commercializes products to treat cardiopulmonary diseases, infectious diseases and cancer. Location Research Triangle Park
Company Vascular BioSciences Inc. Activity: Research and Development Research and Development Company Description Vascular BioSciences is a biopharmaceutical company developing solutions for difficult-to-treat cardiovascular and inflammatory diseases. Location Durham
Company Velo Bio LLC Activity: Research and Development Research and Development Company Description Velo Bio is developing an orphan drug for the treatment of severe preeclampsia in pregnant women. Location Morrisville
Company X-in8 Biologicals Corp. Activity: Research and Development Research and Development Company Description X-in8 Biologicals develops technologies to prevent and treat ischemia reperfusion injury in the context of organ transplant, myocardial infarction and stroke. Location Chapel Hill
Company Xollent Biotech Inc. Activity: Research and Development Research and Development Company Description Xollent Biotech is developing a therapeutic to treat cardiovascular disease based on exosome-secreting cells. Location Cary